The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Timofeeva A.A.

Belozertseva I.I.

FGBU DPO «Sankt-Peterburgskij institut usovershenstvovanija vrachej-ekspertov», Sankt-Peterburg, Rossija

The issues of medical/social expertise in Parkinson’s disease

Authors:

Timofeeva A.A., Belozertseva I.I.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(9): 93‑97

DOI: 10.17116/jnevro20161169193-97

Read: 18737 times

Download PDF (RU)
Contact the author
Table of contents

THE ISSUES OF MEDICAL/SOCIAL EXPERTISE IN PARKINSON’S DISEASE
THE ISSUES OF MEDICAL/SOCIAL EXPERTISE IN PARKINSON’S DISEASE

To cite this article:

Timofeeva AA, Belozertseva II. The issues of medical/social expertise in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(9):93‑97. (In Russ.)
https://doi.org/10.17116/jnevro20161169193-97

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Art and creativity in Parkinson’s disease: the mysterious effe­cts of dopa­mine. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):13-20
Correlation of motor symptoms and cardiovascular dysfunction in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):59-67
Diagnosis of pathological and adaptive bala­nce changes in Parkinson’s disease to select a reha­bilitation program. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):88-94
Sleep diso­rders in patients with Lewy body deme­ntia and Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):81-87
Effect of uric acid on the progression of Parkinson’s disease: Myth or reality?. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):7-14
Change of speech diso­rders during bila­teral deep stimulation of the subthalamic nucleus of the brain in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):59-65
Oxidative stress and depression in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):131-138
Current aspe­cts of the rela­tionship between depression and cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10):66-74
Pote­ntial and prospects of the astragaloside IV use for age-associated diseases prevention. Russian Journal of Preventive Medi­cine. 2025;(7):94-99
Dyna­mics of permeability of the blood-brain barrier after FUS thalamotomy acco­rding to contrast-enhanced MRI. Burdenko's Journal of Neurosurgery. 2025;(4):51-60
Abstract:

Parkinson’s disease (PD) is a chronic progressive neurodegenerative disease that restricts activities of daily living. The prevalence of PD and inevitable disability show the importance of medical/social expertise (MSE) in the system of care for PD patients. Currently, the MSE is based on the Hoehn and Yahr scale that indicates the prevalence of disease but does not evaluate the severity of symptoms. To assess restrictions of activities of daily living, one should consider non-motor symptoms of PD, movement fluctuations and dyskinesia, the efficacy and tolerability of pharmacological treatment, the use of invasive treatment methods (deep brain stimulation, intrajejunal introduction of duodopa).

Keywords:

Parkinson’s disease
medical/social expertise
disability criteria
Parkinson’s disease
medical/social expertise
disability criteria

Authors:

Timofeeva A.A.

Belozertseva I.I.

FGBU DPO «Sankt-Peterburgskij institut usovershenstvovanija vrachej-ekspertov», Sankt-Peterburg, Rossija

Close metadata

References:

  1. Levin OS, Fedorova NV. Bolezn' Parkinsona. M.: MEDpress-inform; 2014. (In Russ.).
  2. Shtok VN, Ivanova-Smolenskaja IA, Levin OS. Jekstrapiramidnye rasstrojstva. M.: MEDpress-inform; 2002. (In Russ.).
  3. Odin P, Russmann A, Bremenhaven А, Aquilonius SM. Pump-driven continuous duodenal administration of levodopa. A new therapy for patients with advanced Parkinson’s disease. Psychopharmakotherapie. 2005;12:223-227.
  4. Levin OS, Dokadina LV. Jepidemiologija parkinsonizma i bolezni Parkinsona. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2005;5:41-48. (In Russ.).
  5. Levin OS. Klinicheskaja jepidemiologija bolezni Parkinsona. Chast' I. Annotirovannye doklady. Rukovodstvo dlja vrachej po materialam II Nacional'nogo kongressa po bolezni Parkinsona i rasstrojstvam dvizhenij (s mezhdunarodnym uchastiem). M., 21—23 sentjabrja 2011;5-9. (In Russ.).
  6. Berger K, Breteler M, Helmer C, Inzitari D, Fratiglioni L, Trenkwalder C, Hofman A, Launer LJ. Prognosis with Parkinsons Disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54(suppl 5):24-27.
  7. Lees AJ. Drugs for Parkinsons disease. J Neurol Neurosurg Psychiat. 2002;73:607-610.
  8. Hoehn M, Yahr H. Parkinsonism: Onset, Progression and Mortality. Neurology. 1967;17:427-442.  doi: 10.1212/wnl.17.5.427
  9. Klinicheskaja nevrologija s osnovami mediko-social'noj jekspertizy. Rukovodstvo dlja vrachej. Pod red. Makarova AJu. SPb.: OOO «Medlajn-Media»; 2006. (In Russ.).
  10. Shindrjaeva NN. Analiz invalidnosti pri Bolezni Parkinsona. Aspirantskij vestnik Povolzh'ja. 2011;5-6:103-106. (In Russ.).
  11. Levin OS, Smolenceva IG, Ivanov AK. Nedvigatel'nye fljuktuacii pri bolezni Parkinsona. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2010;3:90-96 (In Russ.).
  12. Chaudhuri KR, Healy DG, Schapira AH. Nonmotor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol. 2006;5:3:235-245.
  13. Martinez-Martin P, Rodriguez-Blazquez C, Abe K, Bhattacharyya K, Bloem BR, Carod-Artal FJ, Prakash R, Esselink RA, Falup-Pecurariu C, Gallardo M, Mir P, Naidu Y, Nicoletti A, Sethi K, Tsuboi Y, van Hilten JJ, Visser M, Zappia M, Chaudhuri KR. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology. 2009;73(19):1584-1591. doi: 10.1212/WNL.0b013e3181c0d416
  14. Schrag A. Entacapon in the treatment of Parkinson’s disease. Lancet Neurol. 2005;4:366-370.
  15. Hely MA, Morris JG, Reid WG, Trafficante R. Sydney multicenter study of Parkinson's disease. Mov Disord. 2005;20:190-199.  doi: 10.1002/mds.21956
  16. Fahn S. Medical treatment of Parkinsons disease J Neurology. 1998;245(suppl 3):15-24.
  17. Fahn S, Elton RL. Unified rating scale for Parkinson’s disease. In: Recent developments in Parkinson’s disease. Florham Park. New York: Macmillan; 153—163.
  18. Tomskij AA, Shabalov VA. Hronicheskaja jelektrostimuljacija subtalamicheskogo jadra v lechenii bolezni Parkinsona. Zhurnal voprosy nejrohirurgii im. N.N. Burdenko. 2004;2:40-44. (In Russ.).
  19. Timofeeva AA. Lechenie pozdnih stadij bolezni Parkinsona: obzor jeffektivnosti i bezopasnosti levodopa-karbidopa intestinal'nogo gelja. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2014;11:145-151. (In Russ.).
  20. Fernandez H, Standaert D, Hauser R, Lang A, Fung V, Klostermann F, Lew M, Odin P, Steiger M, Yakupov E, Chouinard S, Suchowersky O, Dubow J, Chatamra K, Robieson W, Benesh J, Espay A. Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: Final 12-Month, Open-Label Results. Mov Disord. 2015;30:4:601-609. doi: 10.1002/mds.26123 
  21. Eggert K, Schrader C, Hahn M, Stamelou M, Rüssmann A, Dengler R, Oertel W, Odin P. Continuous jejunal levodopa infusion in patients with advanced parkinson disease: practical aspects and outcome of motor and non-motor complications. Clin Neuropharmacol. 2008;31:151-166.  doi: 10.1097/wnf.0b013e31814b113e
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.